Ten years of stroke programmes in Poland: Where did we start? Where did we get to?

International Journal of Stroke

Volumn 5, Issue 5, 2010, Pages 414-416

  Członkowska, Anna ^a,b   Niewada, Maciej ^a,b   Sarzyñska Długosz, Iwona ^a   Kobayashi, Adam ^a   Skowroñska, Marta ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MANNITOL; PIRACETAM; VINPOCETINE;

ARTICLE; BLOOD CLOT LYSIS; CAROTID ANGIOPLASTY; DISABILITY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MONITORING; MORTALITY; PATIENT CARE; PHYSIOTHERAPY; POLAND; PRIORITY JOURNAL; SPEECH THERAPY; STENT; STROKE; STROKE UNIT;

HUMANS; NATIONAL HEALTH PROGRAMS; POLAND; REGISTRIES; STROKE;

EID: 77956251701     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00470.x     Document Type: Article

References (12)

1. Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970-1985. Stroke 1990, 21:989-92.
2. Czlonkowska A, Ryglewicz D, Weissbein T, Baranska-Gieruszczak M, Hier DB. A prospective community-based study of stroke in Warsaw, Poland. Stroke 1994, 25:547-51.
3. Aboderin I, Venables G. Stroke management in Europe. Pan European Consensus Meeting on Stroke Management. J Intern Med 1996, 240:173-80.
4. Niewada M, Skowronska M, Ryglewicz D, Kaminski B, Czlonkowska A. Acute ischemic stroke care and outcome in centres participating in the Polish National Stroke Prevention and Treatment Registry. Stroke 2006, 37:1837-43. Polish National Stroke Prevention and Treatment Collaborative Group.
5. Czlonkowska A, Sarzynska-Dlugosz I, Niewada M, Kobayashi A, Ryglewicz D. Evaluation of the accessibility of stroke units in Poland. Neurol Neurochir Pol 2004, 38:353-60.
6. Czlonkowska A, Sarzynska-Dlugosz I, Niewada M, Kobayashi A. Eligibility of stroke units in Poland for administration of intravenous thrombolysis. Eur J Neurol 2006, 13:220-4.
7. Brainin M, Olsen TS, Chamorro A. Organization of stroke care: education, referral, emergency management and imaging, stroke units and rehabilitation. European Stroke Initiative. Cerebrovasc Dis 2004, 17((Suppl. 2)):1-14.
8. Kobayashi A, Czlonkowska A, Ahmed N. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the safe implementation of thrombolysis in stroke (SITS) registry. Acta Neurol Scand 2009, DOI, 10.1111/j.1600-0404.2009.01294.x, [Epub ahead of print].
9. Kobayashi A, Bembenek J, Dowzenko A, Skowronska M, Sarzynska-Dlugosz I, Czlonkowska A. Carotid artery stenting in ischaemic stroke prevention: initial results from the national programme of prevention and treatment of cardiovascular diseases POLKARD. Post Kardiol Interw 2006, 2:259-65.
10. Giroud M, Czlonkowska A, Ryglewicz D, Wolfe C. The problem of interpreting variations in health status (morbidity and mortality) in Europe. Stroke Services. Policy and Practice in Europe 2002, 1-17. Wolfe C, McKevitt C, Rudd A, in, (eds), 1st edn, Abingdon, Radcliffe Medical Press Ltd
11. Czlonkowska A, Sarzynska-Dlugosz I, Kwolek A, Krawczyk M. Evaluation of needs in early post-stroke rehabilitation in Poland. Neurol Neurochir Pol 2006, 40:471-7.
12. Postȩpowanie w udarze mózgu. Wytyczne Grupy Ekspertów Narodowego Programu Profilaktyki i Leczenia Chorób Układu Sercowo-Naczyniowego POLKARD. Neurol Neurochir Pol 2008, 42:S201-88. Grupa Ekspertów Narodowego Programu Profilaktyki i Leczenia Chorób Układu Sercowo-Naczyniowego POLKARD